HomeAbout

TL;DR CNBC


FDA approves controversial new drug designed to slow the progression of ALS - TL;DR CNBC

FDA approves controversial new drug designed to slow the progression of ALS

Publishing timestamp: 2022-09-29 21:22:15


Summary


Sentiment: NEGATIVE

Tickers: AMLX

Keywords:

Source: https://www.cnbc.com/2022/09/29/fda-approves-controversial-new-drug-designed-to-slow-the-progression-of-als-.html


Developed by Leo Phan